Difference between revisions of "FtsZ"
(→Reviews) |
|||
Line 110: | Line 110: | ||
=== Additional information=== | === Additional information=== | ||
+ | ** the novel antibiotic ADEP (acyldepsipeptides) causes [[FtsZ]] degradation via dysregulation [[ClpP]] activity (activity occurs even in the absence of an ATPase subunit ([[ClpC]], [[ClpE]], or [[ClpX]])) {{PubMed|21969594}} | ||
=Expression and regulation= | =Expression and regulation= |
Revision as of 09:32, 31 October 2011
- Description: cell-division initiation protein (septum formation)
Gene name | ftsZ |
Synonyms | ts-1 |
Essential | yes PubMed |
Product | cell-division initiation protein (septum formation) |
Function | formation of Z-ring |
Interactions involving this protein in SubtInteract: FtsZ | |
MW, pI | 40 kDa, 4.814 |
Gene length, protein length | 1146 bp, 382 aa |
Immediate neighbours | ftsA, bpr |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
|
Contents
Categories containing this gene/protein
cell division, essential genes, membrane proteins
This gene is a member of the following regulons
The gene
Basic information
- Locus tag: BSU15290
Phenotypes of a mutant
essential PubMed
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity:
- Protein family: ftsZ family (according to Swiss-Prot)
- Paralogous protein(s):
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s):
- Effectors of protein activity:
Database entries
- UniProt: P17865
- KEGG entry: [3]
- E.C. number:
Additional information
Expression and regulation
- Regulatory mechanism:
- Additional information:
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody: available in the Jeff Errington lab
Labs working on this gene/protein
- Imrich Barak, Slovak Academy of Science, Bratislava, Slovakia homepage
- Leendert Hamoen, CBCB, Newcastle University, UK
Your additional remarks
References
Reviews
Additional reviews: PubMed
FtsZ as antibacterial drug target
Other original Publications
Additional publications: PubMed